FGF23 and chronic kidney disease: Beyond its role as a phosphataemic regulator, circulating FGF23 is a strong predictor of disease progression and mortality in patients with chronic kidney disease (CKD), in whom higher levels of this hormone are prevalent, with an emerging role in cardiovascular disease [18,19,20].